No Detail Found!

Mitigation of addictive effects induced by lorazepam through concurrent administration of SSRI: Interplay of serotonin and dopamine in caudate and nucleus accumbens

Author(s)
Huma Ikram Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi,Karachi,Pakistan
Iqra Atique Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi,Karachi,Pakistan
Umaira M Moosa Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi,Karachi,Pakistan
Darakhshan Jabeen Haleem Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi,Karachi,Pakistan; Neuroscience Research Laboratory, Dr Panjwani Center for Molecular Medicine and Drug Research, ICCBS, University of Karachi,Karachi,Pakistan
Abstract
The present study aimed to assess the antidepressant profile of fluoxetine in the rats exhibiting lorazepaminduced abusive effects in place preference paradigm. Lorazepam, a benzodiazepine is commonly utilized for treating anxiety, panic attacks, status epilepticus, depressive disorders and sedation. Despite its therapeutic benefits, repeated lorazepam administration can lead to dependence, possibly involving heightened dopaminergic neurotransmission. Additionally, an important role is played by serotonergic system in anxiety and addiction pathophysiology and treatment. The study aimed to examine fluoxetine's impact on lorazepam-induced addiction, as fluoxetine, a selective serotonin reuptake inhibitor, enhances 5-HT availability by inhibiting its reuptake in neurons. Behavioral parameters, including growth rate, food intake, behaviors in forced swim test, open field, light dark box test, Skinner's box and conditioned place preference, were monitored in rats subjected to oral lorazepam (2 mg/kg) and fluoxetine (1mg/kg) administration. Neurochemical analysis suggests that fluoxetine enhances serotonin levels, which counteracts the dopamine-driven addictive effects of lorazepam within the caudate and nucleus accumbens. This supports the notion that serotonindopamine interplay facilitates mitigate dependency by stabilizing the reward pathways following lorazepam administration.
Publication Details
Page(s) 1043-1051
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Addiction, Fluoxetine, Lorazepam, conditioned place preference, SSRI
0

Citations

0

Downloads

78

Views